Lunai Bioworks Inc.
LNAI
$2.33
$0.041.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.53% | -26.73% | |||
| Depreciation & Amortization | -2.65% | -72.77% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.58% | -26.37% | |||
| Operating Income | 21.72% | 26.37% | |||
| Income Before Tax | -42.90% | -163.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -42.90% | -163.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -42.90% | -163.83% | |||
| EBIT | 21.72% | 26.37% | |||
| EBITDA | 22.06% | 25.57% | |||
| EPS Basic | -34.26% | -161.21% | |||
| Normalized Basic EPS | 24.65% | 27.51% | |||
| EPS Diluted | -34.26% | -161.21% | |||
| Normalized Diluted EPS | 24.65% | 27.51% | |||
| Average Basic Shares Outstanding | 6.44% | 4.27% | |||
| Average Diluted Shares Outstanding | 6.44% | 4.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||